feed,title,long_url,short_url
MarketWatch,Viatris stock slides 24% as analysts say sale of biosimilars to Indian partner removes key growth driver,http://www.marketwatch.com/news/story.asp?guid=%7B20C05575-04D4-B545-79E0-1CAAD54B3A04%7D&siteid=rss&rss=1,https://on.mktw.net/3McxdEQ
